-
Identifying CKD As a Key Driver of CVD Deaths
Sep 9, 2025, 16:22 PM -
Correlation Between Extension Survival Benefits and Incremental Costs of Oncology Drugs in Portugal: A Cross-Sectional, Regression Analysis
Sep 9, 2025, 16:22 PM -
The Cost of Complacency: Projecting the Burden of HIV Care in Eight European Countries
Sep 9, 2025, 16:22 PM -
Where Is AI in Evidence Synthesis for NICE HTA Submissions?
Sep 9, 2025, 16:22 PM -
The Socioeconomic Value of Adult Respiratory Immunization Programs in Spain: How Much Can We Gain From Expanding Prevention Efforts?
Sep 9, 2025, 16:22 PM -
NICE and CDA Assessment of Artificial Intelligence-Enabled Health Technologies: Analysis and Insights
Sep 9, 2025, 16:22 PM -
Evaluating a Deep Learning Model for Classifying Pediatric Pneumonia in Israel
Sep 9, 2025, 16:22 PM -
Early Life Hypoglycemia and Neurological Sequalae in Children With Congenital Hyperinsulinism
Sep 9, 2025, 16:22 PM -
AI-Enabled Extraction of eGFR and BRAF Testing Patterns in Advanced NSCLC: IMPACT-NSCLC, a Multicenter Real-World Study (2019-2024)
Sep 9, 2025, 16:22 PM -
Improving Patient Involvement in Cancer Clinical Trials: Development of Plain Language Checklists Within the SISAQOL-IMI Initiative
Sep 9, 2025, 16:22 PM -
An Evaluation of the Cost of Treatment for Low-Back Pain Among Patients Attending Public Healthcare Facilities in Nigeria
Sep 9, 2025, 16:22 PM -
Development of a Discrete Choice Experiment to Explore Preferences for Self-Sampling in a National UK Cervical Screening Program
Sep 9, 2025, 16:22 PM -
Unlocking the Value of RSV Adult Vaccination With Adjuvanted RSVpreF3 Vaccine in Spain: A Return on Investment Analysis Using an Integrated Actuarial Macroeconomic Model
Sep 9, 2025, 16:22 PM -
Worth Their Weight? Cost-Effectiveness and Access Decisions for GLP-1 and GIP/GLP-1 Therapies
Sep 9, 2025, 16:22 PM -
Is NICE’s Proportionate Approach Achieving Its Objective: Analysis of Time to Access for Cost Comparison vs. Single Technology Appraisal
Sep 9, 2025, 16:22 PM -
Impact of Nirsevimab on the Health Burden and Costs of Respiratory Syncytial Virus (RSV) in the Infant Population From the Healthcare System in Argentina
Sep 9, 2025, 16:22 PM -
Development of Cardiovascular Risk Equations: Integrating Clinical Expertise With Data From the SELECT Trial
Sep 9, 2025, 16:22 PM -
Sex Differences in Patients With Chronic Hand Eczema (CHE): Disease Manifestations and Quality of Life (QoL) Results From a Cross-Sectional Multinational Study
Sep 9, 2025, 16:22 PM -
Personalized Treatment Optimization Using Reinforcement Learning on Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
Mapping of Treatment Patterns and Transfusion Status in Danish and Swedish Myelofibrosis (MF) Patients
Sep 9, 2025, 16:22 PM
